idecabtagene vicleucel
2seventy bio,bms
['car t', 'multiplemyeloma', 'idecabtagene vicleucel']
today at #asco22, doris hansen shares real-world experience on idecabtagene vicleucel car t-cell therapy for relapsed/refractory #multiplemyeloma. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.